SCHEMBL3810220

SCHEMBL3810220

COc1ccc(Cl)cc1S(=O)(=O)N(Cc1cccc(F)c1)[C@@H]1CCN(C#N)C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP30 Q70CQ3 3/20 0.42
F10 P00742 1/20 0.41
CTSL P07711 1/20 0.41
CTSB P07858 1/20 0.41
CTSS P25774 1/20 0.41
CTSK P43235 1/20 0.41
CTSC P53634 1/20 0.41
PSEN1 P49768 6/20 0.39
PSEN2 P49810 6/20 0.39
APH1B Q8WW43 6/20 0.39
NCSTN Q92542 6/20 0.39
APH1A Q96BI3 6/20 0.39
PSENEN Q9NZ42 6/20 0.39
RAB9A P51151 2/20 0.39
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
TSHR P16473 1/20 0.38
ATM Q13315 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
ALDH1A1 P00352 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3813983 0.91 TSHR (0.42) USP30F10CTSLCTSBCTSS
SCHEMBL3808181 0.91 CTSL (0.52) USP30F10CTSLCTSBCTSS
SCHEMBL3816124 0.91 CTSL (0.47) USP30F10CTSLCTSBCTSS
SCHEMBL3816173 0.91 LMNA (0.44) USP30F10CTSLCTSBCTSS
SCHEMBL3806625 0.90 PGR (0.45) USP30F10CTSLCTSBCTSS
SCHEMBL3810169 0.90 CTSL (0.41) USP30CTSLCTSBCTSSCTSK
SCHEMBL3811330 0.89 CTSL (0.42) USP30F10CTSLCTSBCTSS
SCHEMBL3816137 0.88 CTSL (0.40) USP30F10CTSLCTSBCTSS
SCHEMBL3814085 0.87 PSEN1 (0.45) USP30F10CTSLCTSBCTSS
SCHEMBL3811448 0.86 RORC (0.46) USP30CTSLCTSBCTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090264498-A1 Cathepsin C Inhibitors GLAXO GROUP LIMITED (GB) 2009-10-22 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264498-A1 Cathepsin C Inhibitors CTSF, CTSZ, CTSG USP30 955/4885F10 1859/4885CTSL 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.